China Universal Asset Management Company’s LENZ Therapeutics LENZ Stock Holding History

China Universal Asset Management Company’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.3K	Sell	4,990 -563	-10%	-$4.54K	﹤0.01%	486
2026 Q1	$50.8K	Buy	5,553 +454	+9%	+$6.38K	﹤0.01%	453
2025 Q4	$81.6K	Sell	5,099 -2,900	-36%	-$84.5K	0.01%	421
2025 Q3	$373K	Buy	7,999 +2,346	+42%	+$86.3K	0.03%	275
2025 Q2	$166K	Buy	5,653 +137	+2%	+$3.73K	0.02%	327
2025 Q1	$142K	Sell	5,516 -315	-5%	-$7.76K	0.01%	339
2024 Q4	$168K	Buy	+5,831	New	+$178K	0.02%	339
2023 Q4	–	Sell	-212	Closed	-$3.68K	–	484
2023 Q3	$3.68K	Buy	212 +103	+94%	+$1.79K	﹤0.01%	406
2023 Q2	$1.98K	Sell	109 -4	-4%	-$80	﹤0.01%	428
2023 Q1	$1.93K	Buy	113 +29	+35%	+$469	﹤0.01%	432
2022 Q4	$1.96K	Buy	84 +6	+8%	+$139	﹤0.01%	373
2022 Q3	$2K	Buy	+78	New	+$1.86K	﹤0.01%	364

Other funds holding LENZ

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return

Corient Private Wealth Miami, Florida $78.6B AUM 28.08% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

China Universal Asset Management Company's LENZ Position: Q2 2026 in Review

China Universal Asset Management Company reduced its LENZ Therapeutics (LENZ) stake by 10% in Q2 2026, selling an estimated $4.54K and leaving 4,990 shares worth $28.3K. The position accounts for ﹤0.01% of the portfolio, ranked #486.

China Universal Asset Management Company first reported a position in LENZ in Q3 2022 and has held it in 12 quarters since. The position peaked at $373K in Q3 2025. 65 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

China Universal Asset Management Company held 4,990 shares of LENZ Therapeutics worth $28.3K as of Q2 2026.
China Universal Asset Management Company sold 563 LENZ Therapeutics shares in Q2 2026, an estimated $4.54K.
LENZ Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #486 holding.
China Universal Asset Management Company first reported a position in LENZ Therapeutics in Q3 2022 and has held it in 12 quarters since.
China Universal Asset Management Company's LENZ Therapeutics position peaked at $373K in Q3 2025.
65 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.